Northwestern Mutual Wealth Management
RGC icon

Northwestern Mutual Wealth Management’s Regencell Bioscience RGC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-301
Closed -$7.65K – 4395
2026
Q1 		$7.65K Hold
301
– – ﹤0.01% 3164
2025
Q4 		$6.32K Buy
+301
New +$4.89K ﹤0.01% 3145

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Northwestern Mutual Wealth Management's RGC Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Regencell Bioscience (RGC) in Q2 2026, closing a stake of 301 shares — an estimated $7.65K sold.

Northwestern Mutual Wealth Management first reported a position in RGC in Q4 2025 and held it in 2 quarters. The position peaked at $7.65K in Q1 2026. 35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Regencell Bioscience position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 301 Regencell Bioscience shares in Q2 2026, an estimated $7.65K.
  • Northwestern Mutual Wealth Management first reported a position in Regencell Bioscience in Q4 2025 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Regencell Bioscience position peaked at $7.65K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.